PMID- 16601780 OWN - NLM STAT- MEDLINE DCOM- 20070828 LR - 20191210 IS - 1213-8118 (Print) IS - 1213-8118 (Linking) VI - 149 IP - 2 DP - 2005 Dec TI - Modulator of intracellular Ca(2+), thapsigargin, interferes with in vitro secretion of cytokines and nitric oxide. PG - 321-4 AB - Interference of thapsigargin (TG), an inhibitor of endoplasmic reticulum Ca(2+) ATPase, with immune reactivity of murine macrophages was investigated under conditions in vitro. The activation of cells with lipopolysaccharide (LPS), interferon-(gamma) (IFN-(gamma)), and with acyclic nucleoside phosphonate N(6)-isobutyl-9-[2-(phosphonomethoxy)ethyl]- 2,6-diaminopurine (N(6)-isobutyl-PMEDAP) resulted in enhanced production of cytokines TNF-alpha, IL-10, chemokines RANTES/CCL5 and MIP-1alpha/CCL3, as well as in substantially augmented production of nitric oxide (NO) triggered by IFN-(gamma). The effects were in a dual mode of action influenced by TG (1 microM). While TG upregulated secretion of TNF-alpha, it inhibited secretion of IL-10 and RANTES. The immune-stimulated secretion of MIP-1alpha remained virtually unaffected, though TG on its own activated expression of MIP-1alpha in macrophages. The high-output NO production induced by IFN-(gamma), high concentrations of LPS, or by combination of IFN-(gamma) plus LPS or N(6)-isobutyl-PMEDAP was inhibited by TG. On the other hand, production of NO which was marginally activated by low concentration of LPS was upregulated by TG. FAU - Kmonickova, Eva AU - Kmonickova E AD - Institute of Experimental Medicine, Academy of Sciences, Prague, Czech Republic. kmonickova@biomed.cas.cz FAU - Canova, Nikolina Kutinova AU - Canova NK FAU - Farghali, Hassan AU - Farghali H FAU - Holy, Antonin AU - Holy A FAU - Zidek, Zdenek AU - Zidek Z LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - Czech Republic TA - Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub JT - Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia JID - 101140142 RN - 0 (Cytokines) RN - 0 (Enzyme Inhibitors) RN - 0 (Immunosuppressive Agents) RN - 0 (Lipopolysaccharides) RN - 0 (Tumor Necrosis Factor-alpha) RN - 31C4KY9ESH (Nitric Oxide) RN - 5EX1YUR4DH (9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine) RN - 67526-95-8 (Thapsigargin) RN - 82115-62-6 (Interferon-gamma) RN - EC 7.2.2.10 (Calcium-Transporting ATPases) RN - GAN16C9B8O (Glutathione) RN - JAC85A2161 (Adenine) RN - SY7Q814VUP (Calcium) SB - IM MH - Adenine/analogs & derivatives/pharmacology MH - Animals MH - Calcium/*metabolism MH - Calcium-Transporting ATPases/antagonists & inhibitors MH - Cells, Cultured MH - Cytokines/*biosynthesis MH - Endoplasmic Reticulum/metabolism MH - Enzyme Inhibitors/pharmacology MH - Female MH - Glutathione/metabolism MH - Immunosuppressive Agents/pharmacology MH - Interferon-gamma/pharmacology MH - Lipopolysaccharides/pharmacology MH - Macrophages/metabolism MH - Mice MH - Mice, Inbred C57BL MH - Nitric Oxide/*biosynthesis MH - Thapsigargin/*pharmacology MH - Tumor Necrosis Factor-alpha/biosynthesis EDAT- 2006/04/08 09:00 MHDA- 2007/08/29 09:00 CRDT- 2006/04/08 09:00 PHST- 2006/04/08 09:00 [pubmed] PHST- 2007/08/29 09:00 [medline] PHST- 2006/04/08 09:00 [entrez] PST - ppublish SO - Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2005 Dec;149(2):321-4.